NO20064902L - Imidazopyridinforbindelse - Google Patents
ImidazopyridinforbindelseInfo
- Publication number
- NO20064902L NO20064902L NO20064902A NO20064902A NO20064902L NO 20064902 L NO20064902 L NO 20064902L NO 20064902 A NO20064902 A NO 20064902A NO 20064902 A NO20064902 A NO 20064902A NO 20064902 L NO20064902 L NO 20064902L
- Authority
- NO
- Norway
- Prior art keywords
- alkyl group
- substituted
- hydrogen atom
- group
- compound
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
En forbindelse representert ved følgende generelle formel (1) eller et salt eller et hydrat derav: hvori R1 representerer en C1-C6 alkylgruppe eller C2-C6 alkynylgruppe, hvilket kan være substituert eller en fenylgruppe hvilket kan være substituert, R2 representerer et hydrogenatom eller en C1-C6 alkylgruppe, R3 representerer metyl- eller etylgruppe, R4 representerer en C1-C6 alkylgruppe, R5 representerer et hydrogenatom, tilveiebringer en forbindelse hvori R1 er C1-C6 alkylgruppe usubstituert eller substituert med et halogenatom og R2 er ekskludert med et hydrogenatom.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004126533 | 2004-04-22 | ||
PCT/JP2005/008311 WO2005103049A1 (en) | 2004-04-22 | 2005-04-21 | Imidazopyridine compound |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20064902L true NO20064902L (no) | 2006-12-04 |
Family
ID=35196916
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20064902A NO20064902L (no) | 2004-04-22 | 2006-10-26 | Imidazopyridinforbindelse |
Country Status (17)
Country | Link |
---|---|
US (2) | US20050272764A1 (no) |
EP (1) | EP1737862A4 (no) |
JP (1) | JP4749335B2 (no) |
KR (1) | KR20070007149A (no) |
CN (1) | CN1976929A (no) |
AU (1) | AU2005235906A1 (no) |
BR (1) | BRPI0509986A (no) |
CA (1) | CA2562812A1 (no) |
IL (1) | IL178774A0 (no) |
MX (1) | MXPA06011993A (no) |
NO (1) | NO20064902L (no) |
NZ (1) | NZ550624A (no) |
RU (1) | RU2373206C2 (no) |
SG (1) | SG151251A1 (no) |
TW (1) | TW200606163A (no) |
WO (1) | WO2005103049A1 (no) |
ZA (1) | ZA200608769B (no) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPWO2008047853A1 (ja) * | 2006-10-19 | 2010-02-25 | 味の素株式会社 | 胃食道逆流症の予防・治療剤 |
CN101492452B (zh) * | 2008-01-25 | 2010-11-17 | 山东轩竹医药科技有限公司 | 含有二氧杂环庚烷并吡啶的巯基苯并咪唑衍生物 |
CN101492464B (zh) * | 2008-01-25 | 2011-01-12 | 山东轩竹医药科技有限公司 | 含有二氧杂环庚烷并吡啶的巯基咪唑并吡啶衍生物 |
CN101497622B (zh) * | 2008-01-30 | 2011-04-27 | 山东轩竹医药科技有限公司 | 吡啶甲基亚磺酰基咪唑并吡啶衍生物 |
EP2733141B1 (en) * | 2011-07-15 | 2019-01-09 | Shionogi & Co., Ltd. | Azabenzimidazole derivative having ampk-activating activity |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE8300736D0 (sv) | 1983-02-11 | 1983-02-11 | Haessle Ab | Novel pharmacologically active compounds |
DE3579436D1 (de) | 1984-12-18 | 1990-10-04 | Otsuka Pharma Co Ltd | Tetrahydrochinolin- derivate, verfahren zu deren herstellung und diese enthaltende antimagengeschwuerzusammensetzungen. |
JPS62207271A (ja) | 1986-03-06 | 1987-09-11 | Yamanouchi Pharmaceut Co Ltd | 2−ピリジルメチルチオ基または2−ピリジルメチルスルフイニル基で置換された縮合環化合物 |
JPH0643426B2 (ja) * | 1986-07-25 | 1994-06-08 | 東京田辺製薬株式会社 | イミダゾ〔4,5−b〕ピリジン誘導体、その製造法及びそれを含有する抗潰瘍剤 |
JPH0222273A (ja) | 1987-07-21 | 1990-01-25 | Yoshitomi Pharmaceut Ind Ltd | ピリジン化合物およびその医薬用途 |
JPH0633261B2 (ja) | 1988-01-22 | 1994-05-02 | 東京田辺製薬株式会社 | 新規なイミダゾ[4,5−bピリジン誘導体、その製造法及びそれを含有する抗潰瘍剤 |
DE59102514D1 (de) | 1990-05-18 | 1994-09-15 | Zahnradfabrik Friedrichshafen | Verfahren zur dämpfung von schwingungen in hydraulikanlagen. |
SE9002206D0 (sv) | 1990-06-20 | 1990-06-20 | Haessle Ab | New compounds |
PL165898B1 (pl) | 1990-06-20 | 1995-02-28 | Astra Ab | Sposób wytwarzania nowych pochodnych dwualkoksyplrydynylobenzlmldazolu PL |
JPH05117268A (ja) | 1991-10-22 | 1993-05-14 | Yoshitomi Pharmaceut Ind Ltd | ピリジン化合物 |
US6852739B1 (en) | 1999-02-26 | 2005-02-08 | Nitromed Inc. | Methods using proton pump inhibitors and nitric oxide donors |
JP2002537336A (ja) | 1999-02-26 | 2002-11-05 | ニトロメド インコーポレーテッド | ニトロソ化およびニトロシル化されたプロトンポンプ阻害剤、組成物および使用方法 |
MY148805A (en) | 2002-10-16 | 2013-05-31 | Takeda Pharmaceutical | Controlled release preparation |
-
2005
- 2005-04-06 TW TW094110839A patent/TW200606163A/zh unknown
- 2005-04-21 WO PCT/JP2005/008311 patent/WO2005103049A1/en active Application Filing
- 2005-04-21 AU AU2005235906A patent/AU2005235906A1/en not_active Abandoned
- 2005-04-21 RU RU2006141255/04A patent/RU2373206C2/ru not_active IP Right Cessation
- 2005-04-21 MX MXPA06011993A patent/MXPA06011993A/es unknown
- 2005-04-21 SG SG200901636-1A patent/SG151251A1/en unknown
- 2005-04-21 EP EP05737039A patent/EP1737862A4/en not_active Withdrawn
- 2005-04-21 CA CA002562812A patent/CA2562812A1/en not_active Abandoned
- 2005-04-21 JP JP2006532581A patent/JP4749335B2/ja not_active Expired - Fee Related
- 2005-04-21 BR BRPI0509986-2A patent/BRPI0509986A/pt not_active IP Right Cessation
- 2005-04-21 NZ NZ550624A patent/NZ550624A/en unknown
- 2005-04-21 KR KR1020067021873A patent/KR20070007149A/ko not_active Application Discontinuation
- 2005-04-21 ZA ZA200608769A patent/ZA200608769B/xx unknown
- 2005-04-21 US US11/110,756 patent/US20050272764A1/en not_active Abandoned
- 2005-04-21 CN CNA2005800115589A patent/CN1976929A/zh active Pending
-
2006
- 2006-03-22 US US11/385,786 patent/US7781452B2/en not_active Expired - Fee Related
- 2006-10-19 IL IL178774A patent/IL178774A0/en unknown
- 2006-10-26 NO NO20064902A patent/NO20064902L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
IL178774A0 (en) | 2007-02-11 |
US7781452B2 (en) | 2010-08-24 |
KR20070007149A (ko) | 2007-01-12 |
AU2005235906A1 (en) | 2005-11-03 |
CN1976929A (zh) | 2007-06-06 |
EP1737862A4 (en) | 2007-11-28 |
EP1737862A1 (en) | 2007-01-03 |
US20050272764A1 (en) | 2005-12-08 |
SG151251A1 (en) | 2009-04-30 |
BRPI0509986A (pt) | 2007-10-16 |
TW200606163A (en) | 2006-02-16 |
RU2373206C2 (ru) | 2009-11-20 |
JP2007533630A (ja) | 2007-11-22 |
WO2005103049A1 (en) | 2005-11-03 |
ZA200608769B (en) | 2008-06-25 |
CA2562812A1 (en) | 2005-11-03 |
RU2006141255A (ru) | 2008-05-27 |
JP4749335B2 (ja) | 2011-08-17 |
US20060167041A1 (en) | 2006-07-27 |
NZ550624A (en) | 2009-08-28 |
MXPA06011993A (es) | 2007-04-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20074763L (no) | (1,5-difenyl-1H-pyrazol-3-yl)oksadiazolderivater, fremgangsmate ved fremstilling derav og anvendelse av samme i terapi | |
RS20060316A (en) | Derivatives of n-/heteroaryl(piperidine-2-yl)methyl/ benzamide, preparation method and application of same in therapeutics | |
NO20092770L (no) | Nye aminopyrimidinderivater som PLK1-inhibitorer | |
MX2010001773A (es) | Metodo para preparar derivados de 5-haloalquil-4,5-dihidroisoxasol . | |
EP1338595A3 (en) | Xanthine derivatives as DPP-IV inhibitors | |
TW200619207A (en) | HDAC inhibitor | |
RS51101B (sr) | Inhibitori hcv ns3 proteaze | |
WO2009156861A8 (en) | Substituted pyrimidone derivatives | |
CA2494047A1 (en) | Method for preparing 3-halo-4,5-dihydro-1h-pyrazoles | |
ATE388146T1 (de) | 1-isopropyl-2-oxo-1,2-dihydropyridin-3- carbonsäureamidderivate mit agonistischer wirkung am 5-ht4-rezeptor | |
RS54047B1 (en) | PROCEDURE FOR OBTAINING 4-OXOCHINOLINE COMPOUNDS | |
WO2008136444A1 (ja) | 縮合複素環誘導体 | |
NO20053449L (no) | 3-substituerte 4-pyrimidonderivater | |
NO20071008L (no) | Fremgangsmate for fremstilling av N-piperidino-1,5-difenylpyrazol-3-karboksamidderivater | |
NO20074311L (no) | Kinazolinderivat med tyrosinkinase-inhiberendeaktivitet | |
NO20064902L (no) | Imidazopyridinforbindelse | |
WO2009118473A3 (fr) | Composés dérivés d'azétidines, leur préparation et leur application en thérapeutique | |
WO2008003854A3 (fr) | Derives de 2-benzoyl-imidazopyridines, leur preparation et leur application en therapeutique | |
TNSN07439A1 (en) | Derivatives of,4,5 - diarylpyrrole, preparation method thereof and use of same in therapeutics | |
TNSN08161A1 (en) | 6-heteroarylpyridoindolone derivatives, their preparation and therapeutic use thereof | |
TW200517387A (en) | Compounds exhibiting thrombopoietin receptor agonism | |
EA200700767A1 (ru) | Способ получения пиразолов | |
GB0326964D0 (en) | Chemical compounds | |
TW200700419A (en) | 5,6-dialkyl-7-aminoazolopyrimidines, their preparation and their use for controlling harmful fungi, and compositions comprising these compounds | |
ATE445619T1 (de) | Pyridinylpyrazolopyrimidinon-derivate als pde 7 inhibitoren |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |